Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
We compare the 2024 outlook for index funds and target date funds to help you choose the right retirement path.
23,982 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
U.S. inflation climbs above 4% for the first time since 2023, renewing pressure on the Fed and prompting traders to r...
A fintech founder chose financial discipline over prestige, turning down an invitation from President Obama to focus ...
A U.S. Polo Assn. CEO faced a promotion snub, then outworked every competitor for six months to seize the role and dr...
Chief sustainability officers pitch climate action as a business investment tied to cash flow and risk management. CE...
Abbott Laboratories moved higher after boosting its profit outlook and signaling strength across its diagnostics and ...
A massive new funding request for Iran-related operations has financial markets and households weighing the longer-te...
As lawmakers grapple with federal spending, fresh numbers show social security benefits costs are manageable today, a...
If you want steady income and long-term growth, these five dividend stocks right now combine durable dividends with s...
On his 72nd birthday, a famous pilot adds another credential. This isn’t just a celeb moment—it's a case study in avi...
Investors study the math behind replacing a $75,000 salary with monthly dividend ETFs, weighing yield, risk, and long...
A family earning $340K faces $200K in debt and weighs an extra college loan, spotlighting how lifestyle choices can d...